Skip to main content
. 2021 Nov 22;40(4):555–565. doi: 10.23876/j.krcp.21.900

Figure 1. Blocking points for renin-angiotensin-aldosterone system inhibitors and a neprilysin inhibitor.

Figure 1.

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor-neprilysin inhibitor; AT1R, angiotensin II receptor type 1; AT2R, angiotensin II receptor type 2; MRA, mineralocorticoid antagonist.